AI Time Journal
Aparna Deshpande, PhD, Trinity’s Head of Insights & Analytics, was featured in an interview with AI Time Journal. Read the article to learn more about driving pharmaceutical innovation through Insights and Analytics. Read Now…
MM+M
Trinity’s Lisa Bailey, Ph.D., Managing Director & Head of DEI Strategy, was featured in an article by MM+M. Learn about Trinity’s study on the most pressing challenges facing efforts to include more diverse patient populations in clinical trial research and what drugmakers can do at the corporate level to make a difference. Read Now…
PharmaVoice
“When you look at the list of 50-plus FDA approvals [in 2023], we know from pattern recognition that there’s going to be winners and losers, and some who have to work harder for it — we’ve seen increasing difficulty of achieving success,” said Leslie Orne. Read more from Leslie Orne, Trinity Life Sciences’ President and CEO, in PharmaVoice‘s latest article on ‘Avoiding the pharma ‘junk pile’ with launch readiness, pipeline rigor and ‘quick kills.’ Read Now…
Endpoint News
The Annual Digital Marketing Competency Report was featured in Endpoint News. Read Now…
Pharmaceutical Executive
Leslie Orne speaks with Pharmaceutical Executive about current trends in the life sciences industry and the ways that companies can react. Read Now…
Adam Mendler
Trinity’s President & CEO, Leslie Orne, sat down with Adam Mendler to discuss the significance of setting big goals, listening and leading by example. Read the interview to learn more. Read Now…
Healthcare Technology Report
The Healthcare Technology Report included our President & CEO, Leslie Orne, in The Top 25 Women Leaders in Biotechnology of 2023 list. Read Now…
MM+M
Trinity Life Sciences President & CEO, Leslie Orne, gives her view on the future of pharma commercialization in an interview with Marc Iskowitz. Listen to the MM+M Medical Marketing and Media podcast to hear more. Listen Now…
Pharmaceutical Commerce Magazine
Trinity experts were featured in Pharmaceutical Commerce Magazine Trinity’s Nandini Hadker, Nabha Naga Subramanya and Adrienne Lovink were featured in Pharmaceutical Commerce Magazine’s article “The Business Case for RWE.” Read the article to learn more about how drugmakers can better harness real-world evidence to drive their clinical and commercial objectives, while also providing greater clarity for healthcare providers and improved access to therapy for the patients they serve. Read Now…
MM+M
As the pharma services sector continues to consolidate, RWD is emerging as a critical piece of the commercialization offering. Trinity Life Sciences’ President & CEO, Leslie Orne, was featured in an article in MM+M to discuss this topic. Read Now…
